4SC AG

Biotechnology

Products/services: 4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. Such drugs are intended to provide patients with innovative treatment options that are more tolerable and efficacious than existing therapies and provide a better quality of life. 4SC’s pipeline is protected by a comprehensive portfolio of patents and currently comprises three key drug candidates in various stages of preclinical and clinical development: resminostat, 4SC-202 and 4SC-208. 4SC aims to generate future growth and enhance its enterprise value by entering into partnerships with pharmaceutical and biotech companies and/or the eventual marketing and sales of approved drugs in select territories by 4SC itself. 4SC is headquartered in Planegg-Martinsried near Munich, Germany. The Company had 47 employees as of 31 March 2018 and is listed on the Prime Standard of the Frankfurt Stock Exchange (VSC; ISIN: DE000A14KL72). 4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. Such drugs are intended to provide patients with innovative treatment options that are more tolerable and efficacious than existing therapies and provide a better quality of life. 4SC’s pipeline is protected by a comprehensive portfolio of patents and currently comprises three key drug candidates in various stages of preclinical and clinical development: resminostat, 4SC-202 and 4SC-208. 4SC aims to generate future growth and enhance its enterprise value by entering... read more 

    • Short facts
      • Research & Development
    • Year founded 1997
    • 47 Employees (site)
    • Turnover: <5m EUR
    Company
    4SC AG
    Street
    Frauenhoferstr. 22
    PC/City
    82152 Planegg-Martinsried
    County
    München / Upper Bavaria
    Phone
    +49 89 700763-0
    Fax
    +49 89 700763-29
    Email
    public@4sc.com
    Homepage
    http://www.4sc.de
    Language skills
    English, German
    Contact person
    Management: Dr. Jason Loveridge (Mr.)
    Location Map
    Key to Bavaria Map
  • Core competencies

    not available

    Key sectors / sub-sectors
    • Biotechnology: Bioinformatics and cheminformatics
    • Biotechnology: Preclinical development
    • Biotechnology: Therapeutic drug development
    NACE industries
    • Manufacture of basic pharmaceutical products and pharmaceutical preparations 21
    • Manufacture of pharmaceutical preparations 21.2
    • Manufacture of pharmaceutical preparations 21.20
    • Scientific research and development 72
    Certifications / awards

    not available

    Sales markets - target industries
    not available
    Sales markets - target countries
    not available
    Cooperation offers
    not available